Zopf Kathrin, Frey Kathrin R, Kienitz Tina, Ventz Manfred, Bauer Britta, Quinkler Marcus
Department of EndocrinologyDiabetes and Nutrition, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Department of Medicine IEndocrine and Diabetes Unit, University Hospital, University of Würzburg, Würzburg, Germany.
Endocr Connect. 2017 Nov;6(8):685-691. doi: 10.1530/EC-17-0269. Epub 2017 Sep 27.
Patients with primary adrenal insufficiency (PAI) or congenital adrenal hyperplasia (CAH) are at a high risk of adrenal crisis (AC). Glucocorticoid sensitivity is at least partially genetically determined by polymorphisms of the glucocorticoid receptor (GR).
To determine if a number of intercurrent illnesses and AC are associated with the GR gene polymorphism I in patients with PAI and CAH.
This prospective, longitudinal study over 37.7 ± 10.1 months included 47 PAI and 25 CAH patients. During the study period, intercurrent illness episodes and AC were documented.
The study period covered 223 patient years in which 21 AC occurred (9.4 AC/100 pat years). There were no significant differences between I polymorphisms (CC ( = 29), CG ( = 34) and GG ( = 9)) regarding BMI, hydrocortisone equivalent daily dose and blood pressure. We did not find a difference in the number of intercurrent illnesses/patient year among I polymorphisms (CC (1.5 ± 1.4/pat year), CG (1.2 ± 1.2/pat year) and GG (1.6 ± 2.2/pat year)). The occurrence of AC was not significantly different among the homozygous (GG) genotype (32.5 AC/100 pat years), the CC genotype (6.7 AC/100 pat years) and the CG genotype (4.9 AC/100 pat years). Concomitant hypothyroidism was the highest in the GG genotype group (5/9), compared to others (CC (11/29) and CG (11/34)).
Although sample sizes were relatively small and results should be interpreted with caution, this study suggests that the GR gene polymorphism I may not be associated with the frequencies of intercurrent illnesses and AC.
原发性肾上腺皮质功能减退症(PAI)或先天性肾上腺皮质增生症(CAH)患者发生肾上腺危象(AC)的风险很高。糖皮质激素敏感性至少部分由糖皮质激素受体(GR)的多态性在基因上决定。
确定在PAI和CAH患者中,一些并发疾病和AC是否与GR基因多态性I相关。
这项为期37.7±10.1个月的前瞻性纵向研究纳入了47例PAI患者和25例CAH患者。在研究期间,记录并发疾病发作和AC情况。
研究期间涵盖223患者年,其中发生21次AC(9.4次AC/100患者年)。在BMI、氢化可的松等效日剂量和血压方面,I多态性(CC(=29)、CG(=34)和GG(=9))之间无显著差异。我们未发现I多态性之间在并发疾病/患者年数量上有差异(CC(1.5±1.4/患者年)、CG(1.2±1.2/患者年)和GG(1.6±2.2/患者年))。纯合子(GG)基因型(32.5次AC/100患者年)、CC基因型(6.7次AC/100患者年)和CG基因型(4.9次AC/100患者年)之间AC的发生率无显著差异。与其他组(CC(11/29)和CG(11/34))相比,GG基因型组中合并甲状腺功能减退症的比例最高(5/9)。
尽管样本量相对较小,结果应谨慎解读,但本研究表明GR基因多态性I可能与并发疾病和AC的发生率无关。